Clinical development plan: l-Selenomethionine.
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000517:prevention & control*; D009374:Neoplasms, Experimental; D012107:Research Design; D012645:Selenomethionine / Q000494:pharmacology / Q000627:therapeutic use*
D016588:Anticarcinogenic Agents; D012645:Selenomethionine